Scan the ingredient panel on almost any generic "brain blend" or all-in-one multivitamin marketed for focus, and you'll often see familiar names — bacopa, alpha GPC, L-theanine, ginkgo. On paper it can look similar to Cognitive Support. The real differences aren't always visible from the ingredient list alone, and one of them is a structural quirk of U.S. supplement law that's worth understanding before you compare any two products by their label.
The proprietary blend problem
Under the Dietary Supplement Health and Education Act of 1994, a company can group several ingredients into a "proprietary blend" and legally disclose only the blend's total weight and the names of the ingredients inside it — not how much of each ingredient is actually in there.1 A 2023 peer-reviewed analysis in The Journal of Nutrition lays this out plainly: this practice, intended to protect trade secrets, means the amount of any single ingredient in a proprietary blend often isn't available for calculating real-world exposure or comparing it to the dose used in clinical trials.1 In plain terms: a "brain blend" can list bacopa monnieri on the front of the bottle without you ever being able to confirm whether it's dosed anywhere near what the human trials for bacopa actually used, or present at a token amount.
A proprietary blend can legally list an ingredient's name without ever telling you how much of it is actually in the capsule.
Where Cognitive Support stands today, honestly
Cognitive Support's ingredients are listed individually, not grouped into an undisclosed blend — there's no umbrella label hiding what's inside. That said, we're not going to overstate our own position: individual per-ingredient milligram doses aren't fully on the label yet either, and that's a real, acknowledged gap we're closing one ingredient at a time, beginning with GABA and moving through the rest from there. The structural difference that matters today is this: nothing here is permanently hidden behind a blend-weight loophole by design — the remaining doses are a timeline problem we're actively working through, not a trade-secret choice we're making indefinitely.
A generic multivitamin is solving a different problem entirely
Separately from the blend-disclosure issue, a standard multivitamin marketed with "brain support" language is usually built around RDA-level doses of vitamins and minerals — amounts calibrated to prevent a nutrient deficiency, not to hit the specific, higher doses used in the human trials for a targeted nootropic ingredient like bacopa monnieri or alpha GPC. Taking a multivitamin doesn't substitute for an ingredient dosed to the range a clinical trial actually tested; it's solving for "not deficient," not "cognitive performance under demand."
What to actually check when comparing two products
Three questions cut through most of the marketing noise, regardless of brand: does the label group ingredients into an undisclosed "proprietary blend," or list them individually? Is each named ingredient backed by multiple independent human trials, not a single small or industry-funded study? And where a dose is disclosed, does it match what those trials actually used, or is it a fraction of it? Our fuller breakdown of how to read a label for exactly this covers the mechanics in more detail.2
References
- Saldanha LG, Dwyer JT, Hardy CJ, MacKay DJ. "Perspectives on the Use of Proprietary Blends in Dietary Supplements." The Journal of Nutrition, 2023. pmc.ncbi.nlm.nih.gov
- "How to Read a Supplement Label: A Practical Guide to Proprietary Blends and Underdosing." Proco. procohq.com
This article is for informational purposes only and has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Speak with a healthcare provider before starting any new supplement, especially if you take medication or have an existing health condition.
Related reading: Single-Ingredient vs. Blend: How to Choose
See Cognitive Support's individually-listed ingredients at procohq.com — no undisclosed blend.